Washington: Administering to patients stem cells derived from their own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial.The results of the trial, called Transplantation in Myocardial Infarction Evaluation (TIME), mirror a previous, related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function.Both TIME and LateTIME were conducted by the Cardiovascular Cell Therapy Research Network (CCTRN), sponsored by the NIH’s National Heart, Lung, and Blood Institute.“This study was extremely valuable even though it did not provide a demonstrated health benefit after six months,” said Sonia Skarlatos, PhD, deputy director of NHLBI’s Division of Cardiovascular Sciences and member of the CCTRN.
Tejas closer to induction into IAF
No plans to drop charges against Khobragade: US
`Dhoom 3` audience verdict
Lieutenant Governor Najeeb Jung recommends President`s rule in Delhi